Dagmar Pich

Center for Environmental Health — United States

Medicine · Health Sciences

23h-index2.9kcitations40works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(27), Cytomegalovirus and herpesvirus research(19), Herpesvirus Infections and Treatments(6), Parvovirus B19 Infection Studies(6), Lymphoma Diagnosis and Treatment(4)

Publications40 total

Assessing the fitness of Epstein-Barr virus following its reactivation
Journal of Virology·2025Open Access
SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests
Biomedicines·2023· 3 citedOpen Access
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
Vaccines·2023· 7 citedOpen Access
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
PNAS Nexus·2022· 11 citedOpen Access
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
2021Open Access
Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and composition
2021Open Access
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection
PLoS Pathogens·2021· 29 citedOpen Access
Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus
mBio·2021· 51 citedOpen Access
Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
Nucleic Acids Research·2021· 31 citedOpen Access
Multiple viral microRNAs regulate interferon release and signaling early during infection with Epstein-Barr virus
2020· 1 citedOpen Access
Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL
Biomarker Research·2020· 10 citedOpen Access
Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL
Figshare·2020Open Access
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
mBio·2019· 110 citedOpen Access
Inducible transgene expression in PDX models <i>in vivo</i> identifies KLF4 as therapeutic target for B-ALL
2019Open Access
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Proceedings of the National Academy of Sciences·2019· 213 citedOpen Access
The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus
2019· 5 citedOpen Access
Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
2019· 3 citedOpen Access
Epstein-Barrウイルスに感染したナイーブヒトBリンパ球の寿命の最初の日【JST・京大機械翻訳】
Mbio·2019
Epstein-Barr virus reprograms human B-lymphocytes immediately in the pre-latent phase of infection
2018· 14 citedOpen Access
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
The Journal of Immunology·2012· 446 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Wolfgang Hammerschmidt(40), Reinhard Zeidler(9), Paulina Mrozek-Górska(9), Aloys Schepers(7), Alexander Buschle(5), Ezgi Akidil(5), Manuel Albanese(5), Henri‐Jacques Delecluse(4), Josef Mautner(4), Mickaël Bouvet(4), Yen‐Fu Adam Chen(4), Oliver T. Keppler(4), Bill Sugden(3), Stephan Hamperl(3), Andreas W. Thomae(3), Bianca Mocanu(3), Johannes Roessler(3), Verena Krähling(3), Stephan Becker(3), Wen‐Hsin Liu(3)